» Articles » PMID: 6314860

Pathogenesis of Lower Respiratory Tract Symptoms in Experimental Rhinovirus Infection

Overview
Specialty Pulmonary Medicine
Date 1983 Nov 1
PMID 6314860
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the pathogenesis of lower respiratory tract symptoms during rhinovirus infection, 19 healthy young adult volunteers were exposed to a currently unnumbered rhinovirus strain (HH). Spirometry and bronchoprovocation with histamine sulfate were performed prior to and on Days 4, 5, and 21 after exposure to the virus. Fiberoptic bronchoscopy for visualization and culture of the tracheobronchial mucosa was done on Day 4 or Day 5. Fourteen of 19 volunteers were infected with rhinovirus; 9 of the 14 had clinical illness. Rhinovirus was isolated from the bronchial brush specimens in 5 of the 13 infected volunteers bronchoscoped, all of whom had clinical illness. Rhinovirus was not isolated at bronchoscopy from any of the 5 infected volunteers without clinical illness (p = 0.025, Fisher's exact test). Spirometry and histamine bronchoprovocation were unchanged during experimental rhinovirus infection. Rhinovirus may invade the lower respiratory tract in symptomatic infections, and thereby cause lower respiratory tract symptoms.

Citing Articles

Rhinovirus C15 Induces Airway Hyperresponsiveness via Calcium Mobilization in Airway Smooth Muscle.

Parikh V, Scala J, Patel R, Corbi C, Lo D, Bochkov Y Am J Respir Cell Mol Biol. 2019; 62(3):310-318.

PMID: 31533004 PMC: 7055698. DOI: 10.1165/rcmb.2019-0004OC.


Rhinovirus Attributes that Contribute to Asthma Development.

Han M, Rajput C, Hershenson M Immunol Allergy Clin North Am. 2019; 39(3):345-359.

PMID: 31284925 PMC: 6624084. DOI: 10.1016/j.iac.2019.03.004.


Neural dysfunction following respiratory viral infection as a cause of chronic cough hypersensitivity.

Undem B, Zaccone E, McGarvey L, Mazzone S Pulm Pharmacol Ther. 2015; 33:52-6.

PMID: 26141017 PMC: 4532602. DOI: 10.1016/j.pupt.2015.06.006.


Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Del Vecchio A, Branigan P, Barnathan E, Flavin S, Silkoff P, Turner R Pulm Pharmacol Ther. 2014; 30:32-43.

PMID: 25445932 PMC: 7110859. DOI: 10.1016/j.pupt.2014.10.005.


Rhinovirus-Induced Exacerbations of Asthma and COPD.

Hershenson M Scientifica (Cairo). 2013; 2013:405876.

PMID: 24278777 PMC: 3820304. DOI: 10.1155/2013/405876.